Project Management White Papers & Case Studies

11. Phase II Primary Insomnia Program In Need Of Full-Service CRO Management 12/6/2012

    Clinilabs, a contract research organization (CRO), was selected by an international drug discovery and development company to provide full-service CRO management of a phase II primary insomnia program.

12. Ethnic Bridging 10/26/2012

    Clinilabs, a contract research organization (CRO), was selected to characterize the pharmacokinetic prole of XXXX following the administration of four doses of XXXX to healthy Japanese and non-Japanese subjects aged 20 to 45 years by assessing serum concentration data over time.

13. Therapeutic Expertise: Neuroscience & CNS Datasheet 3/27/2012
    PRA is a leader in the clinical research industry, providing innovative solutions for CNS drug development.
14. PRA Exceeds Tough Enrollment Goals: Service Delivery Model Drives Positive Results 2/20/2012

    Changes in resources for both the client and PRA teams led to significant challenges with the start-up and enrollment activities in Europe and North America.

15. Human ADME & Studies With Radiolabeled Compounds

    During clinical drug development there can be several situations where the use of radiolabeled medication or other radiolabeled compounds is required or favorable to accomplish the study objectives. This whitepaper is mainly focusing on human ADME studies and “microdose” studies to assess absolute bioavailability (BA). The major part of the information in this overview is also relevant for other clinical studies with a radiolabeled compound. By Ad Roffel and Henk Poelman, PRA Health Sciences